FORM 10-K DEC 31 2013

Company

Cocrystal Pharma, Inc.

Filed

March 31, 2014

Period of Report

December 31, 2013

Accession Number

0001415889-14-001020

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →